SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms Inc. is experiencing a sharp sell-off as investors react to unfavorable court rulings regarding addictive content and rising concerns over heavy AI capital expenditure. The community is actively debating whether this decline represents a major buying opportunity due to strong fundamentals or a deeper structural shift in social media regulation.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing renewed positive momentum driven by a strategic ad partnership with Pacvue that expands its enterprise-scale advertising capabilities. Investors are closely watching ongoing insider buying, which appears to be tempering concerns surrounding previous executive stock sales.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility as traders grapple with conflicting signals regarding the ongoing Middle East conflict and shifting energy market pressures. The community remains deeply divided, with many actively debating whether current price levels represent a prime buying opportunity for a bounce or a dangerous trap that could lead to further downside.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing a intense, multi-week downtrend that has triggered heavy retail frustration and intense speculation regarding the stock's stability. While some investors see this as a generational buying opportunity based on long-term fundamentals, many in the community are actively debating whether shifting market narratives around AI spending and macroeconomic headwinds will lead to further downside.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares surged following positive Phase 3 results for its diabetic retinopathy drug, Zenkuda, which met its primary endpoint with high statistical significance. Investors are actively debating the company's path toward an accelerated FDA submission, the potential for a short squeeze given high short interest, and whether the stock's recent valuation jump is a justified repricing of its pipeline or an opportunity to lock in gains before future capital raises.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is gaining traction as a community-driven permissionless brand, with active members promoting a wide range of real-world initiatives, products, and lifestyle merchandise. The community is actively discussing their long-term conviction, the benefits of dollar-cost averaging, and the unique, grassroots approach to building brand awareness worldwide.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is experiencing heightened market attention following a volatile reaction to interim clinical data for its obesity candidate, WVE-007, which has sparked intense debate over its long-term potential compared to GLP-1 incumbents. While some investors are bullish on the company's RNA-based platform and its unique ability to reduce visceral fat while preserving muscle mass, others remain skeptical about the trial design and are wary of potential further downside as analysts balance ambitious price targets against the challenges of a crowded obesity pipeline.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPY is facing heavy selling pressure as traders brace for potential escalation in the Iran conflict and react to the lack of a market bounce, fueling widespread concerns about institutional distribution and further downside. Market sentiment is dominated by volatility and frustration over contradictory geopolitical headlines, with community members actively debating whether to position for a deeper correction or a possible short-term relief rally.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is seeing heightened investor attention and a strong upward trend, driven by robust commercial execution of its lead therapy, Rezdiffra, and speculation regarding potential long-term acquisition interest from major biopharma players. While the community is actively debating the company's high operating expenses versus its market leadership in the MASH space, technical momentum and positive analyst coverage continue to fuel significant bullish sentiment.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining momentum as investors eye its dual GLP-1/GIP agonist, VK2735, as a high-potential challenger in the multibillion-dollar obesity market. The community remains focused on upcoming trial milestones, viewing the stock as a prime acquisition target due to its clinical progress and clean profile relative to competitors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DELL 
https://ca.finance.yahoo.com/news/dell-director-offloads-hundreds-thousands-125023767.html

Mike

Dell Director Offloads Huge Stake as Insider Selling Accelerates